Phase I Dose Escalation and Pharmacokinetic Study of Enzastaurin, an Oral Protein Kinase C Beta Inhibitor, in Patients With Advanced Cancer The September 1, 2006, article by Goldberg et al entitled, ...
Results from a pooled analysis of data from 12 studies have demonstrated a long-term survival benefit that extends through at least 10 years for patients with advanced melanoma treated with ipilimumab ...
Although randomized studies have shown a beneficial effect of drug-eluting stents in reducing the risk of repeated revascularization, these trials were underpowered to compare rates of death and ...
A review of results from the FIDELITY pooled analysis analyzing finerenone’s impact on cardiorenal morbidity and mortality in patients with type 2 diabetes and CKD. Rajiv Agarwal, MD, MS: Before I ...
Phase II Study of Gemcitabine, Carboplatin, and Iniparib As Neoadjuvant Therapy for Triple-Negative and BRCA1/2 Mutation–Associated Breast Cancer With Assessment of a Tumor-Based Measure of Genomic ...
A pooled analysis of three large trials failed to demonstrate significant reductions in cardiovascular death with finerenone, but significantly lower all-cause mortality, cardiovascular events and ...
Merck (NYSE: MRK), known as MSD outside the United States and Canada, today announced that first-line treatment with KEYTRUDA, Merck’s anti-PD-1 therapy, in combination with chemotherapy demonstrated ...
In a pooled analysis, the high-dose inactivated influenza vaccine provided superior protection compared with the standard-dose vaccine against hospitalisations for influenza or pneumonia; it also ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results